José Alberto Orfao de Matos Correia e Vale-rekin lankidetzan egindako argitalpenak (22)

2023

  1. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

  2. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

2022

  1. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109

2021

  1. The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia

    Frontiers in Cell and Developmental Biology, Vol. 9

2020

  1. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis

    EMBO Journal, Vol. 37, Núm. 14

  2. Loss of Pax5 exploits sca1-BCR-ABLp190 susceptibility to confer the metabolic shift essential for pB-ALL

    Cancer Research, Vol. 78, Núm. 10, pp. 2669-2679

2015

  1. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development

    Oncogene, Vol. 34, Núm. 36, pp. 4777-4790

  2. Erratum: A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development (Oncogene (2015) 34 (4797-4798) DOI: 10.1038/onc.2015.322)

    Oncogene

  3. Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility

    Cancer Discovery, Vol. 5, Núm. 12, pp. 1328-1343

2014

  1. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma

    Nature Communications, Vol. 5

2012

  1. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

    EMBO Journal, Vol. 31, Núm. 18, pp. 3704-3717

2010

  1. Bcl2 is not required for the development and maintenance of leukemia stem cells in mice

    Carcinogenesis, Vol. 31, Núm. 7, pp. 1292-1297

2009

  1. Cancer induction by restriction of oncogene expression to the stem cell compartment

    EMBO Journal, Vol. 28, Núm. 1, pp. 8-20

2005

  1. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples

    American Journal of Clinical Pathology, Vol. 123, Núm. 1, pp. 66-74

2003

  1. Her-2/neu Gene Amplification in Familial vs Sporadic Breast Cancer: Impact on the Behavior of the Disease

    American Journal of Clinical Pathology, Vol. 120, Núm. 6, pp. 917-927

1995

  1. Flow cytometry in the diagnosis of cancer

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 55, Núm. S221, pp. 145-152

1993

  1. Acute lymphoid leukemias following either a previous chronic myelogenous leukemia or myelodysplastic syndrome: Phenotypic and genomic differences

    American Journal of Hematology, Vol. 43, Núm. 4, pp. 256-258

1992

  1. Immunophenotype in erythroleukemia secondary to myelodysplastic syndrome [3]

    Blood